In principle, mRNA vaccines are ideal for health emergencies as they can be quickly mass produced using a template. The problem is that current cell-based template production methods take too long, ...

This advanced MVA manufacturing process is expected to significantly simplify vaccine production, particularly in middle- and low-income regions where supply chain issues often hinder access to ...

So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process ... of our vaccine and therapeutic protein production ...

which is now in the process of catching up.-Timothy Mercer, University of Queensland For Mercer, bringing sequencing methods into that ecosystem was an intuitive solution for improving quality control ...

Africa is taking major steps toward self-sufficiency in vaccine and health product manufacturing, as leaders, manufacturers, and global partners gathered at the 2nd Vaccine & Health Products ...

This site is earmarked for the construction of an end-to-end vaccine manufacturing facility, showcasing Kenya's commitment to healthcare advancement. In 2022, Kenya initiated the process of ...

GeoVax Advanced MVA Manufacturing Process: Aimed to Enhance Vaccine Supply Worldwide 27.01.2025 / 15:04 CET/CEST The issuer is solely responsible for the content of this announcement. Process ...